Article
RUVBL1 and RUVBL2 are druggable MYCN regulators in neuroblastoma
2024-10-04
Abstract excerpt
<h4>ABSTRACT</h4> High-risk neuroblastoma is characterized by MYCN amplification and high MYCN or MYC gene expression. These patients have a poor prognosis and there is an urgent need for more effective drugs. While strategies to develop inhibitors that directly target the MYC proteins have remained largely unsuccessful, recent preclinical studies have identified ATR, a key protein of the DNA damage response,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8b34e4e4-85d6-59ff-9b39-bdd870cbc4ff
- DOI
- 10.1101/2024.10.03.616410
